Can Adrenal Adenoma Worsen Hypothyroidism?
Adrenal adenomas do not directly worsen pre-existing hypothyroidism; however, cortisol-secreting adenomas (causing Cushing syndrome) can suppress TSH secretion and create secondary "corticogenic hypothyroidism," which paradoxically may mask or complicate the diagnosis of primary hypothyroidism. 1, 2
Mechanism of Adrenal-Thyroid Interaction
Cortisol-Secreting Adenomas and Thyroid Function
Excess cortisol from functioning adrenal adenomas suppresses TSH secretion at the pituitary level, leading to low T3 and T4 levels despite inappropriately normal or low TSH—a condition termed "corticogenic hypothyroidism." 1, 2
This suppression occurs even when basal TSH levels appear normal and fail to rise appropriately after TRH stimulation, making the diagnosis challenging. 1
When hypercortisolism is corrected surgically, serum T4 and T3 concentrations typically normalize, confirming that the thyroid dysfunction was secondary to cortisol excess rather than primary thyroid disease. 1
Post-Surgical Considerations
After adrenalectomy for cortisol-secreting adenomas, patients develop tertiary adrenal insufficiency requiring glucocorticoid replacement. 3
Paradoxically, when glucocorticoid replacement is insufficient postoperatively, TSH secretion may recover, but this can unmask or worsen underlying thyroid dysfunction. 2
Conversely, adequate glucocorticoid replacement (35 mg/day hydrocortisone or higher) can re-suppress TSH, potentially causing recurrent secondary hypothyroidism. 2
Clinical Implications for Pre-Existing Hypothyroidism
Non-Functioning Adenomas
Benign non-functioning adrenal adenomas (<10 HU on unenhanced CT) have no direct effect on thyroid function and require no hormonal follow-up. 4
These lesions do not interfere with thyroid hormone metabolism or TSH regulation. 4
Functioning Adenomas
All adrenal incidentalomas must be screened for autonomous cortisol secretion using the 1 mg overnight dexamethasone suppression test, as even subclinical hypercortisolism can affect thyroid axis function. 5
Mild autonomous cortisol secretion (MACS) is associated with metabolic comorbidities including diabetes and hypertension, but its specific impact on pre-existing hypothyroidism is less well-characterized. 5
Diagnostic Pitfalls
Glucocorticoids are among the substances that can interfere with normal circulating TSH levels, making interpretation of thyroid function tests unreliable in the setting of hypercortisolism. 6
A single TSH value should never establish a diagnosis of thyroid dysfunction in patients with adrenal pathology; serial measurements are essential. 6
TSH secretion is highly sensitive to acute illness and medications, and adrenal insufficiency itself can interfere with normal TSH levels. 6
Management Algorithm
For Patients with Known Hypothyroidism and Newly Discovered Adrenal Adenoma
Perform functional evaluation with 1 mg overnight dexamethasone suppression test, plasma ACTH, cortisol, and DHEA-S to exclude autonomous cortisol secretion. 4, 5
If cortisol suppression is normal (<1.8 µg/dL), the adenoma is non-functioning and will not affect thyroid management. 5
If cortisol suppression is abnormal (>5 µg/dL), consider that current thyroid function tests may be unreliable due to TSH suppression. 1, 2
Measure free T4 and T3 directly rather than relying solely on TSH in patients with confirmed hypercortisolism. 1
For Patients Undergoing Adrenalectomy
Initiate stress-dose hydrocortisone perioperatively and taper gradually over weeks. 3
Monitor thyroid function closely during glucocorticoid tapering, as TSH secretion may recover and reveal previously masked primary hypothyroidism. 2
Adjust levothyroxine dosing based on free T4 levels rather than TSH alone during the first 3-6 months post-adrenalectomy. 2
Key Clinical Caveat
The relationship between adrenal adenomas and hypothyroidism is indirect and mediated entirely through cortisol excess. Non-functioning adenomas have no impact, while cortisol-secreting adenomas create a complex interplay that can both mask primary hypothyroidism (through TSH suppression) and complicate its management postoperatively (through variable glucocorticoid replacement needs). 1, 2